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Introduction

A neuronotrophic hypothesis for the adult
central nervous system (CNS) has been increasingly
supported by in vivo studies of Nerve Growth
Factor (NGF) impacts on adult rat CNS cholinergic
neurons. We have extended these investigations to
NGF effects on cholinergic axonal regeneration in
an adult rat septo-hippocampal model. A fimbriaforn ix lesion deprives the dorsal hippocampal
formation (HF) of its cholinergic afferents and
provides a cavity into which sciatic nerve segments
can be implanted to serve as regeneration bridges
from septum to HF. Septa! cholinergic fibers enter
and course through fresh cell-containing nerve
bridges to attain a maximal number by the end of
one month, but enter and grow further into the HF
much more slowly and to a limited depth. The
importance of NGF for axonal regeneration in the
nerve bridge was shown by the demonstration that
an " acellular" nerve preparation deprived of its
NG F-producing living cells fails to be invaded by
the cholinergic fibers, but regains its competence if
pre-incubated in NGF. The importance of NGF for
intra-hippocampal regeneration was documented by
the much greater cholinergic invasion of the HF
induced by local (i.e., intra-hippocampal) NGF
infos ions. Advances in biomaterial science should
provide further progress regarding: i) the continuous
intracerebral delivery of NGF or other protein
factors, and ii) the availability of surrogate materials
as regeneration bridges.

The remarkable progress of neurobiology over
the past decade is providing new opportunities for
potential clinical advances in at least two areas of
neuropathology: neurodegenerative diseases and
neural regeneration. Both areas take advantage of a
neuronotrophic hypothesis of the central nervous
system (CNS) (Varon et al, 1984), which rests on
three main propositions: (1) CNS neurons in the
adult mammal continue to depend on , for their
welfare, function and repair capabilities, a c1ass of
special proteins called neuronotrophic factors
(NTFs); (2) CNS deficits may , therefore, reflect a
relative inadequacy in the availability of endogenous
NTF; and (3) administration of exogenous NTF can
compensate for or supplement an insufficient
endogenous supply and, thus, prevent or alleviate
the resulting neuronal damage. In this article, we
shall
review
recent
in formation
that
has
substantiated such a hypothesis, and will point out
directions in which new biomaterials might provide
advantages for future clinical applications.
CNS cholinergic neurons and Nerve Growth Factor
The breakthrough for testing the CNS
neuronotrophic hypothesis came with the discovery
that Nerve Growth Factor (NGF), a protein factor
best known for its trophic activity on certain
peripheral ganglionic neurons, can also affect
central cholinergic neurons in the basal forebrain
and the neos triatum of the rat (Whittemore and
Seiger, 1987; Hefti et al, 1989). Among the
responsive cholinergic CNS nerve cells, the medial
septum and vertical diagonal band neurons project to
their
innervation
territory,
the
hippocampal
formation, largely through the fimbria-fornix tract.
A complete
fimbria-fornix
transection
(FFT)
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axotomizes these neurons , thereby also interrupting
the retrograde axonal pathway through which they
receive endogenous NGF from their hippocampal
territory. The resulting septal neuron damage (Gage
et al , 1986 ; Hagg et al, 1988) is manifested by a
progressive decline, over the next 2-3 weeks , in the
number of septal neurons that can be recognized as
cholinergic
by
their
s tainability
for
acetylcholinesterase (AChE) or choline acetyltransferase
(ChAT) ,
the
acetylcholine
regulating
enzymes. This apparent loss of cholinergic septal
neurons is largely prevented by intraventricular
administration of exogenous NG F from lesion time
onward (Hefti, 19 86 ; Williams et al, 198 6; Kromer ,
1987) , but will take place if the NGF treatment is
interrupted (Montero and Hefti ,
1988) . The
numerical decline of cholinergic septal neurons is
not due to actual neuronal death but to a reduction of
their cholinergic "markers" beyond current detection
thresho Ids. Exogenous NG F administration starting
after septal neuron disappearance causes their
progressive and nearly complete reappearance even
when the NGF treatment is delayed by as long as 3
months (Hagg et al , 1988 , l 989a). N euronal
recovery upon delayed NGF treatment is not
restricted to the cholinergic enzymes , and includes a
reversal of the immunostainable NGF receptor and
somal size reduction induced by axotomy (Hagg et
al, 1989a).
A recent study (Sofroniew et al , 1990) has
shown that septal cholinergic neurons, although
shrunken, remain detectable with the persistance of
only a very small compacted remnant of fimbriafornix and hippocampal formation after excitotoxic
lesions of the latter. As that study points out it
could be that this remnant, or the reactive astrocytes
in it, provided enough trophic support (NGF) for
the septal neurons or that these neurons acquire
another source of trophic factors.
These , data,
therefore, are not necessarily in conflict with the
neuronotrophic hypothesis but will require further
and more detailed analyses.
The ability of NGF to influence adult CNS
cholinergic neurons has been shown to extend
beyond the acute FFT model. Basal forebrain and
striatal cholinergic neurons play a crucial role in the
cognitive activities of the brain, and learning or
memory deficiencies are accompanied by cholinergic
deficits in the aged brain as well as the
neurodegenerative Alzheimer's disease. Aged rats
selected for learning impairment have been reported

to respond to intraventricular NGF treatments with a
behavioral improvement as well as partial reversal of
an age-induced atrophy in some of their cholinergic
neurons (Fischer et al , 1987), and clinical trials for
intraventricular NGF treatments in Alzheimer's
patients are currently under consideration in several
countries. Exogenous NG F administration can also
upregulate cholinergic neurons in the absence of an
experimental or pathological lesion (Hagg et al,
l 989b; Cavicchioli et al 1989), drawing attention to
the potential importance of local NGF concentrations
for differential effects on different subsets of
neuronal targets.
The septo-hippocampal model for adult CNS
regeneration
The acknowledged failure of adult mammalian
CNS neurons to regenerate their axonal projections
after intracentral damage is no longer attributed to
an intrinsic or acquired inability of the neurons
themselves to regrow an axon, but rather to a
" resistance" of the adult CNS tissue to be re-invaded
by regenerating nerv e fibers. Such a revised
perspective owes a great deal to the work of
Aguayo ' s group , showing that axons from a variety
of adult neurons in the rat brain or spinal cord will
readily grow inside a peripheral nerve "bridge"
(known to favor axonal regeneration from peripheral
neurons) but stop shortly after re-entering CNS
tissue at the other end of the bridge (e.g., Aguayo
1985) . Little, however, has been learned about the
cellular and molecular components that underlie the
regeneration-favorable and -unfavorable features of
peripheral and central neural tissues, respectively.
The septo-hippocampal system has provided
new
opportunities
to
evaluate
the
CNS
neuronotrophic hypothesis with regard to the roles
of a neuronotrophic factor (here, NG F) on the
axonal regeneration of adult CNS neurons (here, the
septal cholinergic ones). Aspirative FFTs, applied
bilaterally, generate a lesion cavity between the
septum and the hippocampal formation on each side
of the brain. The cavity on either side can be
"bridged" by experimental materials to solicit axonal
regrowth from the septal to the hippocampal
regions. In additional experiments, exogenous NG F
can be administered in different locations to
modulate the number of septa} cholinergic neurons
involved, the extent of their axonal regeneration into
the bridge , and/or the depth and distribution patterns
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of the regenerating cholinergic axons within the
hipp campal re-innervation territory.
Figure 1 illustrates this septo-hippocampal
model and its susceptibility to quantitative analyses
(Hag g et al , 1990a) . Part of the brain (Fig. 1, A) is
us ed to provide coron al sections for the evaluation

A

of ChAT-immunos tained septa} cholinergic neurons.
The rest of the brain yields sagittal sections (Fig.
1,B) to be stained for AChE-positive fibers
emerging from the septum (S) into the grafted bridge
tissue(G) and on to the hippocampal formation
(HF). Counting intersections on eyepiece gridlines
positioned perpendicularly to the axis of graft and
HF
allows
a
quantitative
determination
of
choline rgic fibers that: a) ex tend through the
experimental bridge (line N),
b) enter the
cholinergically denervated HF (line 0 = 0. l mm into
the hippocamp a l tissue), and c) advance to different
hippocampal depths (Jines l , 2, 3 = l, 2, and 3 mm
into the H F ).
F igure 2 s umma ri z es the time course of
cholinergic axonal regeneration in adult rats that
have received freshly collected adult peripheral
(sciatic) nerv e grafts in F F T-caused lesion cavities
(but no deliberate adm inistration of NGF)(Hagg et
al, l 990a) . AChE-positive fibers invade the nerve
bridge after l week and reach a maximal number at
the bridge end by about 1 month. Entry into the HF
is achieved by a much smaller number of fibers
(than are available at bridge exit) in the first few
months but continues to increase with time to nearly
match the number of bridge fibers by 6 months post-
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FIG URE 1 The septo-hippocampal model used for
quantification of the effect of trophic factors on
regeneration. A) Schematic diagram of a coronal
section through the forebrain of an adult rat
illustrating the medial septum (MS) area (hatched)
that was counted on both sides for cholinergic
neurons. (AC = anterior commissure , CC = corpus
callosum,
LV
lateral
ventricle,
S TR
neostriatum , ). B) Schematic sagittal representation
of the rat brain illustrating the placement of sciatic
nerve grafts (G) in a lesion gap between the septum
(S) and the hippocampal formation (H). In sagittal
sections determinations were made of the number of
AChE-positive fibers intersecting imaginary lines
through the hippocampal end of the nerve graft at 0. 2 (N), and at 0 . I (O), 1, 2 and 3 mm from the
rostral tip of the hippocampal formation.
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FIG URE 2 Time course of cholinergic axonal
regeneration into sciatic nerve grafts and hippocampal formation. Presented are the maximal
numbers (± SEM) of AChE -pos itive cholinergic
fibers found at different times in single sagittal
sections at the end of a sciatic nerve "bridge" and at
sequential 1 mm distances into the hippocampal
formation. Also presented is the maximal number of
fibers found in normal animals at 0 and 1 mm.
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lesion. Essentially all the entering fibers can
advance 1mm into the HF, but very few of them
penetrate further even after several months. In
control animals, whose lesion cavity received
gelfoam rather than a nerve graft, entry into the HF
by cholinergic fibers (not shown) was as delayed
and as modest as the reaching of the 2mm intra-HF
line by nerve bridge derived fibers. Such results
have
confirmed
for
the
septo-hippocampal
cholinergic system: i) the competence of adult
peripheral nerve tissue to serve as a CNS
regeneration bridge, and ii) the resistance of adult
central nervous tissue to be re-innervated. Such a
resistance, however, appears to vary in space and/or
time with regard to the regenerating fibers made
available by the nerve bridge .

nerve bridge concurrently with the periventricular
sprouting suggests a tropic as well as a trophic effect
of NG F on cholinergic axonal regeneration into CNS
tissue, favoring regrowth toward the regions where
NGF
concentrations would predominate
--as
similarly noted in vitro (e.g. ,Gundersen 1985).
Freshly dissected peripheral nerve contains
living Schwann and other cells which are known to
produce NG F in vitro {Varon et al, 1981; Muir et al,
1989) and in vivo (Heumann et al, 1987). It also
contains a mechano-chemical scaffold, co-axially
oriented along the Schwann cell chains and
composed of basal lamina "tubular" spaces initially
occupied by the now degenerating distal segments of
the nerve axons. An "acellular" nerve preparation
can be obtained {Manthorpe et al, 1989; Hagg et al,
1991) by: i) transecting a sciatic nerve and leaving it
in situ for 6 weeks, to eliminate degenerating axons
and myelin distal to the lesion, ii) collecting the
distal nerve segment and repeatedly freeze-thawing
lcm pieces of it, to lyse all nerve-associated cells,
and iii) culturing the cell-free pieces in vitro in the
presence of peritoneal macrophages, to eliminate
residual cell debris. The final preparation no longer
contains living cells to act as local sources of NGF
but retains the apparently intact scaffold of lamininrich basal lamina tubular spaces {figyru). When
used as a bridge in the septo-hippocampal model,
acellular nerve did not promote entry and elongation
of cholinergic fibers {Manthorpe et al, 1989; Hagg
et al, 1991). However, acellular nerve that was
incubated for 24 hr with NGF before being grafted
as a potential bridge revealed nearly as many fibers
at 1 month as a freshly dissected cellular nerve.
Such results confirmed that: i) performance of a
nerve graft as a regeneration bridge requires local
availability of endogenous or exogenous NGF, and
ii) a cell-free nerve scaffold remains regenerationcompetent when accompanied by the appropriate
neuronotrophic factor.
Safe intraparenchymal infusions have recently
become possible by use of a modified infusion
device which prevents cytotoxic substances leaching
off the osmotic minipump from mixing with the
infusion fluid and causing necrotic Jes ions in the
infused tissue (Vahlsing et al, 1989). As illustrated
in Figure 4 one month long infusions of NG F directly
into the hippocampal formation (Hagg et al, 1990b),
2mm away from the lesion gap, massively increased
the number of cholinergic fibers entering the HF
from a competent nerve bridge as well as the number

NGF roles in septal cholinergic axonal
regeneration
The quantitative observations reviewed thus
far encourage the speculation that NG F, the
neuronotrophic factor for the septal cholinergic
neurons, may control cholinergic regeneration by its
availability : a) in the septal tissue itself, to dictate
which individual neurons are capable of engaging in
a regeneration process, b) in the bridge, to recruit
and support regenerating axons across the gap, and
c) in the hippocampal formation, to sustain further
growth into the innervation territory (for a review
see Hagg 1990c).
Animals implanted with a nerve bridge but not
otherwise supplied with exogenous NG F exhibited
the expected FFT-induced reduction in detectable
septa I
cholinergic
neurons,
suggesting
that
cholinergic axonal regeneration into the bridge
originated from septal neurons spared by the lesion
(Hagg et al, 1990a). Intraventricular administration
of NGF to nerve-implanted rats (data not shown),
while protecting from damage all septal cholinergic
neurons, caused a marked reduction rather than an
increase in the number of cholinergic fibers entering
the nerve bridge. lntraventricular NG F is known to
induce the appearance of cholinergic sprouting in the
dorsal septum (Williams et al, 1986; Hagg et al,
1989b), suggestive of an attempt to regrow fibers
toward the interrupted fimbria-fornix. In our hands,
the cholinergic sprouting induced by intraventricular
NG F, whether in bridge-free or nerve-implanted
rats, appears with a gradient toward the infused
ventricle. The reduced number of fibers entering the
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regenerating cholinergic fibers ( cfr. 2 and 3mm
locations in Fig. 2), like that generated in a nerve
bridge deprived of its cellular NG F sources, can
also be overcome by an increased availability of
local NGF.

of fibers advancing 2 and 3mm into the hippocampal
tissue -- almost reaching the extent of cholinergic
reinnervation that would be seen in untreated HF
several months later. Thus, the apparent resistance
of hippocampal tissue to extensive penetration by
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FIG URE 3 Morphology of normal and acellular
nerve. A) Electron micrograph of a cross-section
through a normal fresh cellular and B) acellular
peripheral
nerve
showing
the
presence
of
endoneurial collagen (open arrows) and basal lamina
(solid arrows) in both nerves and the virtual absence
of cellular debris in most basal lamina tubes
(asterisks). Bar= 2 µm.

;
t.-

C) Anti-laminin stained (fluorescence) cross section
of a fresh cellular and D) acellular peripheral nerve
showing the preservation of smaller diameter
laminin-rich basal lamina tubes in the latter. The
density of tube-shaped laminin-positive structures in
the acellular nerve (2600/mm2) is nearly as high as
that in the cellular one (3000/mm2). Bar= 100 µm.
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FIG URE 4 Infusion of nerve growth factor into the
hippocampal formation promotes its cholinergic
axonal reinnervation. A) One month after fimbriafornix transection and sciatic nerve graft, but no
NGF treatment , many fibers had regrown into the
dorsal hippocampal formation. B) Nerve growth
factor infusion for one month into the dorsal
hippocampal formation (infusion site = asterisk), in
addition to a nerve graft, dramatically increased
hippocampal
re-innervation
by
AChE-positive
fibers, almost reaching the extent of reinnervation
seen after 6 months without NGF treatment (C). Bar
250 µm .

A

-

Potential contributions by biomaterials
Two aspects of the studies just reviewed
would greatly benefit from the development of
suitable biomaterials if they are to progress toward
potential clinical applications : a) the continuous
delivery of the putative therapeutic agent, and b) the
availability of surrogate materials for regeneration
bridges.
NGF delivery into CNS tissue.
The support that NGF provides to basal
forebrain and striatal cholinergic neurons in adult
and aged rats may yield crucial benefits for the
learning disabilities that characterize Alzheimer's
disease.
Similarly,
local
administration
of
exogenous
trophic
factors
directly
into
reinnervation territories may prove necessary for a
substantial regeneration of injured CNS axons.
Peripheral administration of trophic proteins are
likely to be both ineffective and undesirable
ineffective, because of the inability of such
molecules to cross the blood-brain barrier in order
to reach the CNS parenchyma, and undesirable,
because of i) their competence to affect important
peripheral neurons and cause unwanted side effects
and ii) their immunogenicity that may lead to
peripheral production of antibodies and potentially
severe immune reactions.
Central administration
is
demonstrably
effective at much lower doses than would be
required peripherally and can be further improved by
judicious selection of the delivery sites. Continuous
infusions driven by an osmotic minipump through a
cannula permanently implanted intraventricularly or
intraparenchymally have obvious drawbacks for
widespread adoption, mainly because of the risks
for mechanical trauma and infection involved in: i)
the permanent implantation of the cannula and ii) the
required periodic refilling of the infusion reservoir.

·*
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factors, fills the chamber (1 day); (2) fibrin
polymerization from the exudate constructs a noncellular matrix of coaxial fibrin-fibronectin fibers
across the chamber ( 1 week); (3) fibronectinpromoted immigration of fibroblastic, Schwann and
endothelial cells from both stumps converts the
acellular matrix into a vascularized, cellular "nervelike" structure including longitudinal laminin-coated
spaces (3-4 weeks); and (4) the cell-conditioned,
laminin-rich structure promotes the regeneration of
axons out of the proximal stump into and through
the
chamber- bridging
structure,
progressively
followed by axon myelination (3-6 week period).
Experimental manipulations of the chamber fluid and
matrix should, eventually, permit the construction of
an artificial "surrogate" chamber bridge capable of
substituting for the naturally developing one.
Examples in this directions are the reported uses of :
i) biodegradable polymers replacing the silicone tu be
(Molander et al, 1982; Seckel et al, 1984), ii)
laminin-containing gel as a starting chamber matrix
(Madison et al, 198 7), iii) a matrix of preformed
collagenous fibers (Rizvi et al , 1990), and iv)
nitrocellulose-bound or polymer-released
basic
Fibroblast Grow th Factor, a potent angiogenic
protein (Danielsen et al, 1988; Aebischer et al ,
1989); among others . Ultimately, information from
both the "constructionist" approach with the
chamber model and the "reductionist" approach with
the septo-hippocampal model will define optimal
surrogate biomaterials that would serve as competent
bridges for the regeneration of optic nerve and
spinal cord, two CNS structures whose damage
contributes vastly to human pathologic traumata.

Hence, the need for new ways to achieve CNSlocated, long-lasting, slow-delivery sources of NGF
or oth er relevant biological agents.
Polymer science offers various avenues
towa r d solutions of this problem. Polymer pellets
could contain the intended trophic agent itself, and
act
as
local
slow-delivery
depots.
More
interestingly, polymers are under study (e.g., Jaeger
et al , 19 90) which could contain natural or bioengineered cell sources of the desired agent and
regulate its release according to the pore size of the
polymer.
Eventually,
polymer-delivered
agents
could even be designed to stimulate production of
the desired trophic factor by normal host cells, for
example local astroglial cells (Manthorpe et al,
1990) .
Surrogate regeneration bridges.
The septo-hippocampal model has shown that
a freshly dissected nerve bridge can be resolved into
two components : i) the living cells acting as sources
of a required neuronotrophic factor such as NG F,
which can be replaced by their own trophic product,
and ii) a mechano-chemical scaffold providing the
needed geometry and extracellular matrix, which
remains available in acellu lar nerve preparations.
Further investigations are likely to identify which
extracellular matrix elements may be removed
without consequence and, conversely, which of
them remain critical for the scaffold competence - thereby further advancing the reduction of a
competent regeneration scaffold to its minimal
terms. It would then become possible to construct an
equivalent scaffold incorporating the essential
features and, perhaps, even the separately needed
trophic factors.
Such a task will gain considerably from the
use of another experimental system, i.e. the
"chamber" model (Lundborg et al, 1982) already
well investigated for peripheral nerve regeneration.
In this chamber model, the proximal and distal
stumps of a transected sciatic nerve are inserted into
the opposite ends of a silicone tube so as to leave an
interstump gap (the "chamber") of the desired
length. Through this chamber space, a new nerve
structure will regenerate allowing the proximal
axons to regrow through the distal nerve segment to
the appropriate peripheral innervation territories.
The sequence leading to this de novo regenerate
includes the following steps (Williams et al, 1983;
Varon and Williams, 1986): (1) fluid exudate from
the two nerve stumps , rich in neuronotrophic

Acknowledgements
Work reviewed here has been partially
supported by N INDS grants N S-16349 and NS25011, and by NSF grants BNS-81-8847 and BNS88-08285.
References
Aebischer P, Sallessiotis AN, Winn SR
( 1989). Basic fibroblast growth factor released from
synthetic nerve guidance channels is a potent
mediator of nerve regeneration in vivo. J N eurosci
Res 23: 282-289.

89

Varon S., Hagg T., Vahlsing H.L., Manthorpe M.
Hagg T, Vahlsing HL, Manthorpe M, Varon S
( 1990b). Nerve growth factor infusion into the
denervated
adult
rat
hippocampal
formation
promotes its cholinergic reinnervation. J N eurosci
10: 3087-3092.
Hagg T, Manthorpe M, Vahlsing HL, Varon S
( 1990c). Nerve growth factor roles for cholinergic
axonal regeneration in the adult mammalian Central
nervous system. Comm Dev Neurobiol (in press).
Hagg T, Gulati AK, Behzadian MA, Vahlsing
HL, Varon S, Manthorpe M {1991). Nerve growth
factor
promotes
CNS
cholinergic
axonal
regeneration into acellular peripheral nerve grafts.
Exp N eurol (in press).
Hefti F ( 1986). Nerve growth factor promotes
survival of septal cholinergic neurons after fimbrial
transections . J Neurosci 6: 2155-2162.
Hefti F, Hartikka J,Knusel B (1989) .
Function of neu rotrophic factors in the adult and
aging brain and their possible use in the treatment of
neurodegenerative diseases. N eurobiol Aging 10:
515-533.
Heumann R, Korshing S, Bandtlow C,
Thoen en H ( 198 7). Changes of nerve growth factor
synthesis in nonneuronal cells in response to sciatic
nerve transection. J Cell Biol 104:1623-1631.
Jaeger CB, Greene LA, Tresco PA, Winn SR,
Aebischer
P
{1990).
Polymer
encapsulated
dopaminergic cell lines as "alternative neural
grafts". Pro gr Brain Res, (in press).
Kromer LF {1987). Nerve growth factor
treatment after brain injury prevents neuronal death.
Science 235: 214-216.
Lundborg G, Dahlin LB, Danielsen N,
Gelberman RH, Longo FM, Powell HC, Varon S
{1982). Nerve regeneration in silicone chambers:
influence of gap length and presence of distal stump
components. Exp Neurol 76: 361-375.
Madison R, Da Silva CF, Dikkes P, Sidman
RL, Chiu TH, {1987). Peripheral nerve regeneration
with entubation repair: comparison of biodegradable
nerve guides vs polyethylene tubes and the effects
of a laminin containing gel. Exp Neurol 95: 378390.
Manthorpe M, Hagg T, Gulati AK, Behzadian
AM, Vahlsing HL, Varon S (1989). NGF can
replace Schwann cells in peripheral nerve grafts
used for central nervous system regeneration. Soc
Neurosci Abstr 15: 1258.

Aguayo AJ ( 1985). Axonal regeneration from
injured neurons in the adult mammalian central
nervous system. In: Synaptic Plasticity (Cotman CW
, ed), Guillford Press; New York, pp 457-484.
Cavicchioli L, Flanigan T, Vantini G, Fusco
M, Potato P, Toffano G, Walsh F, Leon A (1989).
NGF amplifies the expression of NGF receptor
messenger RN A in mammalian forebrain cholinergic
neurons. Eur J N eurosci 1: 258-262.
Danielsen N, Pettmann B, Vahlsing HL,
Manthorpe M, Varon S ( 1988). Fibroblast growth
factor effects on peripheral nerve regeneration in a
silicone chamber model. J N eurosci Res 20: 3 20330.
Fischer W, Wictorin K, Bjorklund A,
Williams LR,
Varon S, Gage FH
(1987).
Intracerebral infusion of nerve growth factor
ameliorates cholinergic neuron atrophy and spatial
memory impairments in aged rats. Nature 329: 65 68 .
Gage FH., Wictorin K., Fischer W ., Williams
LR., Varon S and Bjorklund A {1986). Retrograde
cell changes in medial septum and diagonal band
following fimbria-fornix transection : quantitative
temporal analysis. Neurosci 19: 241-255 .
Gundersen RW ( 1985). Sensory neurite
growth cone guidance by substrate absorbed nerve
growth factor. J Neurosci Res 13: 199-212.
Hagg T, Manthorpe M, Vahlsing HL, Varon S
(1988). Delayed treatment with Nerve Growth
Factor reverses the apparent loss of cholinergic
neurons after acute brain damage. Exp N eurol
101:303-312.
Hagg T, Fass-Holmes B, Vahlsing HL,
Manthorpe M, Conner JM , Varon S ( 1989a). Nerve
growth factor (NGF) reverses axotomy-induced
decreases in choline acetyltransferase, NGF - receptor
and size of medial septum cholinergic neurons.
Brain Res 505:29-38.
Hagg T, Hagg F, Vahlsing HL, Manthorpe M,
Varon S ( l 989b). Nerve growth factor effects on
cholinergic neurons of neos triatum and nucleus
accumbens in the adult rat. Neurosci 30:95-103.
Hagg T, Vahlsing HL, Manthorpe M, Varon S
( 1990a). Septo-hippocampal cholinergic axonal
regeneration
through
peripheral
nerve
bridges :quantification and temporal development.
Exp Neurol 109: 153-163.

90

REGENERATION BRIDGES IN CNS
Whittemore SR, Seiger A ( 1987). The
expression, localization and functional significance
of B-nerve growth factor in the central nervous
system. Brain Res Rev 12:439-464.
Williams LR, Longo FM, Powell HC,
Lundborg G, Varon S (1983). Spatial-temporal
progress of peripheral nerve regeneration within a
silicone chamber: parameters for a bioassay. J Comp
Neurol 218: 460-470.
Williams LR, Varon S, Peterson GM,
Wictorin K, Fisher W, Bjorklund A, Gage FH
(1986). Continuous infusion of nerve growth factor
prevents forebrain neuronal death after fimbriafornix transection. Proc Natl Acad Sci USA
83:9231-9235.

Manthorpe M, Muir D, Hagg T, Engvall E,
Varon S (19 90) G lial cell laminin and neurite
outgrowth . In : Differentiation and Functions of
Glial Cells, G Levi, Ed., Alan Liss, Inc., pp 135146.
Molander H, Olsson Y, Engkvist 0, Bowald
S, Erikkson I (1982). Regeneration of peripheral
nerve through a polyg]actin tube. Muscle Nerve 5:
54-57.
Montero CN, Hefti F (1988). Rescue of
lesioned septa! cholinergic neurons by nerve growth
factor : specificity and requirement for chronic
treatment. J Neurosci 8: 2986-2999.
Muir D, Gennrich C, Varon S, Manthorpe M
( 1989). Rat sciatic nerve Schwann cell cultures.
Responses to mitogens and production of trophic
and neurite-promoting factors. Neurochem Res 14:
1003-1012.
Rizvi A, Wasserman AJ, Zazanis AG, Silver
FH ( 1990). Regeneration of peripheral nerve using a
collagenous biomaterial s tent. In "Twelth Annual
International Conference , Engineering in Medicine
and Biology Society", Philadelphia PA, (in press) .
Seckel BS, Chiou TH, Nyilas E, Sidman RL
(1984). Nerve regeneration through synthetic
biodegradable nerve guides: regulation by the target
organ. Plastic Reconstruct Surg 74: 173-181.
Sofroniew MY, Galletly NP, Isacson 0,
Svendsen CN (1990) . Survival of adult basal
forebrain cholinergic neurons after loss of target
neurons. Science 24 7:338-342.
Vahlsing HL, Varon S, Hagg T, Fass-Holmes
B, Dekker A, Manley M, Manthorpe M (1989). An
improved device for continuous intraventricular
infusions prevents the introduction of pump-derived
toxins and increases the effectiveness of NGF
treatments. Exp Neurol 105:233-243.
Varon S, Williams LR ( 1986). Peripheral
nerve regeneration in a silicon model chamber:
cellular and molecular aspects. Peripheral Nerve
Repair and Regeneration 1: 9-25.
Varon S, Skaper SD, Manthorpe M ( 1981 ).
Trophic activities for dorsal root and sympathetic
ganglionic neurons in media conditioned by
Schwann and other peripheral cells. Dev Brain Res
1:73-87.
Varon S, Manthorpe M, Williams LR (1984).
N euronotrophic and neu rite-promoting factors and
their clinical potentials. Dev Neurosci 6: 73-100.

Discussion with Reviewer
E.C. Azmitia: Is NGF the only player or could
laminin also have a regeneration promoting role?
Authors: The data presented here show that NGF
is a necessary player but not necessarily a
sufficient one. In the bridge , the laminin-lined
"tunnels" of the nerve scaffold may also be crucial
for axonal advance and guidance -- even though
they do not work without an NGF source. In the
hippocampal tis sue, there are no organized
"la min in tracks" as in the bridge, but la min in-like
materials are present within neurons (Neuron ,
3:721-732) and may have a role to play.
We
conclude that any molecules (laminin or others)
needed
for
choline rgic
re genera ti on
beside
adequate NGF must be already available in the
hippocampal CNS tissue. It may be that laminin
injections could help the trans it ion from nerve
bridge to CNS tissue. Injections of laminin into
adult brain have promoted extension of 5-HTpositive fibers from fetal transplants (J. Chem.
Neuroanat., 1:133-146).
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